Literature DB >> 16864937

Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.

Meng-Chuan Huang1, Tsu-Nai Wang, Yi-Ling Liu, Te-Hsiung Pa, Hung-Ping Tu, Yi-Chia Huang, Wen-Tsan Chang, Ying-Chin Ko.   

Abstract

BACKGROUND: Hypertriglyceridemia (HTG) is a heterogeneous metabolic disorder. The aim of this study was to examine associations among genetic polymorphisms, SstI polymorphism of apolipoprotein CIII (ApoCIII) and Hind III polymorphism of lipoprotein lipase (LPL), environmental factors and risks of HTG. METHODS AND
RESULTS: Two hundred and forty-nine southern Taiwanese aborigines were recruited for a cross-sectional study, which included 90 subjects with triglyceride (TG)>150 mg/dl (HTG) and 159 with TG<or=150 mg/dl (NTG). The frequencies of SstI major allele (S1) and minor allele (S2) of ApoCIII were 66.1% and 33.9% in HTG and 73.6% and 26.4% in NTG (p<0.1). In female subjects, the frequencies of the S2 allele was significantly higher in HTG (0.38) than NTG (0.27) (p<0.04). The frequencies of the LPL HindIII major allele (H+) and minor allele (H-) were similar between HTG (H+ 84.3%; H- 15.7%) and NTG (H+ 78.9%; H- 21.1%). In a multivariate adjusted logistic model, education<or=6 year (odds ratio (OR)=3.71, 95% confidence interval (CI): 1.24-8.13), Amis tribe (OR=3.08, 95% CI: 1.41-6.77), body mass index (BMI)>or=25 (OR=2.22, 95% CI: 1.18-4.16), starchy food consumption>or=3 times/week (OR=1.89, 95% CI: 1.00-3.59) and ApoCIII S2S2 genotype (OR=3.35, 95% CI: 1.10-10.19) were independently (p<0.05) associated with HTG risks. Among ApoCIII S1S1, S1S2 and S2S2 genotypes, ApoCIII and TG concentrations increased (p<0.01) in a dose-responsive manner.
CONCLUSIONS: The ApoCIII S2 variant and environmental factors, including education, tribal background, BMI and starchy food intake, modulate the risks of HTG in aboriginal Taiwanese. Interaction between genetic and environmental factors warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864937     DOI: 10.1253/circj.70.1030

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study.

Authors:  Maryam S Daneshpour; Bita Faam; Mohamad Ali Mansournia; Mehdi Hedayati; Sohrab Halalkhor; Seyed Alireza Mesbah-Namin; Shahla Shojaei; Maryam Zarkesh; Fereidoun Azizi
Journal:  Endocrine       Date:  2011-11-22       Impact factor: 3.633

2.  Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.

Authors:  Yin Ruixing; Li Yiyang; Li Meng; Li Kela; Long Xingjiang; Zhang Lin; Liu Wanying; Wu Jinzhen; Yang Dezhai; Lin Weixiong
Journal:  Lipids Health Dis       Date:  2010-08-17       Impact factor: 3.876

3.  Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease.

Authors:  Jayashree Shanker; Ganapathy Perumal; Veena S Rao; Natesha B Khadrinarasimhiah; Shibu John; Sridhara Hebbagodi; Manjari Mukherjee; Vijay V Kakkar
Journal:  Lipids Health Dis       Date:  2008-09-19       Impact factor: 3.876

4.  Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Authors:  Yongyan Song; Liren Zhu; Mudwari Richa; Ping Li; Yang Yang; Suping Li
Journal:  Lipids Health Dis       Date:  2015-04-18       Impact factor: 3.876

5.  Association of the S2 allele of the SstI polymorphism in the apoC3 gene with plasma apoCIII interacts with unfavorable lipid profiles to contribute to atherosclerosis in the Li ethnic group in China.

Authors:  Minzeng Sun; Lin Chen; Hui Liu; Lihui Ma; Tiansong Wang; Yueli Liu
Journal:  Lipids Health Dis       Date:  2017-11-21       Impact factor: 3.876

6.  SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province.

Authors:  Ahmad Reza Bandegi; Mohsen Firoozrai; Mohammad Reza Akbari Eidgahi; Parviz Kokhaei
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.